Commonwealth Equity Services’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Commonwealth Equity Services’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-288	Closed	-$38K	–	3301
2020 Q3	$38K	Hold	288	–	–	﹤0.01%	2976
2020 Q2	$48K	Hold	288	–	–	﹤0.01%	2854
2020 Q1	$41K	Buy	288 +19	+7%	+$5.81K	﹤0.01%	2704
2019 Q4	$88K	Buy	269 +1	+0.4%	+$459	﹤0.01%	2760
2019 Q3	$134K	Buy	268 +8	+3%	+$4.51K	﹤0.01%	2634
2019 Q2	$157K	Buy	260 +60	+30%	+$36.8K	﹤0.01%	2572
2019 Q1	$122K	Sell	200 -24	-11%	-$13.1K	﹤0.01%	2574
2018 Q4	$81K	Buy	224 +24	+12%	+$12.9K	﹤0.01%	2523
2018 Q3	$135K	Hold	200	–	–	﹤0.01%	2597
2018 Q2	$174K	Hold	200	–	–	﹤0.01%	2505
2018 Q1	$251K	Hold	200	–	–	﹤0.01%	2207
2017 Q4	$299K	Buy	200 +93	+87%	+$147K	﹤0.01%	2054
2017 Q3	$219K	Buy	107 +56	+110%	+$131K	﹤0.01%	2205
2017 Q2	$134K	Hold	51	–	–	﹤0.01%	2334
2017 Q1	$153K	Hold	51	–	–	﹤0.01%	2221
2016 Q4	$76K	Buy	+51	New	+$67.7K	﹤0.01%	2219

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Commonwealth Equity Services's NBRV Position: Q4 2020 in Review

Commonwealth Equity Services sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2020, closing a stake of 288 shares — an estimated $38K sold.

Commonwealth Equity Services first reported a position in NBRV in Q4 2016 and held it in 16 quarters. The position peaked at $299K in Q4 2017. 33 funds tracked by Wall St. Rank hold NBRV as of Q4 2020.

Commonwealth Equity Services reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2020 after selling out during the quarter.
Commonwealth Equity Services sold 288 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2020, an estimated $38K.
Commonwealth Equity Services first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2016 and held it in 16 quarters.
Commonwealth Equity Services's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $299K in Q4 2017.
33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2020.

Based on Commonwealth Equity Services's 13F filing for Q4 2020, filed 11 Feb 2021.